(CercleFinance.com) – GenSight Biologics announces today that the Company will participate and present data on LUMEVOQ at medical conferences in the coming weeks.
On Tuesday, March 14, Dr. Catherine Vignal, from the Center Hospitalier National D’Ophtalmologie des Quinze-Vingts, Paris, will present a poster at the North American Neuro Ophthalmology Society (NANOS) in Orlando.
That same day, Dr. Patrick Yu-Wai-Man, PhD, of the University of Cambridge, Dr. Alfredo A. Sadun, PhD, and Dr. Mark L. Moster, of Wills Eye Hospital and Thomas Jefferson University, Philadelphia will also present data.
In April, several data presentations will take place at The American Academy of Neurology (AAN) Annual Meeting, held in Boston.